Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.780
+0.010 (0.36%)
Mar 6, 2026, 3:49 PM EST - Market open
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2024. The number of employees decreased by 9 or -45.00% compared to the previous year.
Employees
11
Change (1Y)
-9
Growth (1Y)
-45.00%
Revenue / Employee
n/a
Profits / Employee
-$1,981,003
Market Cap
11.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Imunon | 25 |
| Longeveron | 25 |
| Moleculin Biotech | 17 |
| Soligenix | 16 |
| BioVie | 13 |
| Akari Therapeutics, | 9 |
| Phio Pharmaceuticals | 5 |
CLRB News
- 2 days ago - Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates - GlobeNewsWire
- 9 days ago - Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026 - GlobeNewsWire
- 17 days ago - Cellectar Biosciences Expands Global Intellectual Property Estate - GlobeNewsWire
- 2 months ago - Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies - GlobeNewsWire
- 4 months ago - Cellectar Biosciences, Inc. (CLRB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire